5 year experience of Transthoracic Echocardiographic assessment of left ventricular systolic dysfunction in Hormone receptor positive Breast cancer patients on Trastuzumab therapy
positive breast cancer patients. However it is known to cause cardiomyopathy with left ventricular systolic dysfunction in about 27%, with NYHA class ¾ symptoms in 16% of cases. Consequently, guidelines suggest…

